An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Amgen Inc. (IR) seeks a Senior Associate, DAM Admin to govern digital assets and metadata across Amgen’s global platform. You will validate, tag, and maintain KM and AL&B elements, ensuring data accuracy across brands and CRM integrations.
Role requires 3–5 years in DAM or metadata operations, with strong knowledge of Veeva Vault and Salesforce. You will support asset retrieval, governance, and cross-functional collaboration in a fast-paced, global setting.
Required: Bachelor’s degree in information management, Library Science, Digital Media, or related field. 3–5 years of experience in Digital Asset Management, metadata operations, or library sciences. Strong working knowledge of Veeva Vault, CRM systems (e.g., Salesforce), and DAM platforms (AGP or equivalent). Demonstrated attention to detail, data accuracy, and content governance. Experience managing multiple priorities in a global or matrixed organization.
Preferred: Familiarity with pharmaceutical marketing materials, regulatory processes, and compliance standards. Working experience with metadata taxonomies and content tagging frameworks. Strong communication skills and ability to collaborate cross-functionally with technical and business teams.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen